Consumer interest in CBD has risen rapidly and is growing fast. The size of the UK CBD market is between 3-6 times larger than previous well quoted estimates (£300M per year vs £100M (Brightfield report).

A report from Marijuana Business Daily. This report provides an in-depth look at the varied cannabis business markets and sectors in Europe.

The Therapeutic Goods Administration as part of the Australian Government Department of Health has published a number of documents as guidance on accessing medicinal cannabis for specific issues.

By Jillian Kubala, MS, RD on April 23, 2019 CBD may promote weight loss by reducing appetite, boosting metabolism, and encouraging the “browning” of fat cells. However, research is currently limited, and more human studies are needed. Access the full article by Healthline here: https://www.healthline.com/nutrition/cbd-oil-for-weight-loss

by Marijuana Business Daily International, 2019 This report provides industry leaders and investors interested in the European markets a realistic estimate of its current market sizes and a detailed analysis of the countries where the most opportunities exist. What it will not provide is long-term, uncertain projections with no basis in data. In 2018, only...

Close to 1,300 pain sufferers from across the country took part in the survey run by Chronic Pain Australia – and it seems medical cannabis has been on the minds of many as an option for managing/treating their pain.

It is safe to predict that new therapeutic agents that affect the activity of the endocannaboinoid system will emerge and become members of our therapeutic armamentarium.

by Bradley E. Alger, Ph.D. The endogenous cannabinoid system—named for the plant that led to its discovery—is one of the most important physiologic systems involved in establishing and maintaining human health. Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. With its complex actions in...

Current levels and dangers of opioid use in the U.S. warrant the investigation of harm-reducing treatment alternatives.

Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning.